Friberg Gregory R — SEC Form 4 filings

SEC reporting owner CIK 2038768. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-11.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-10-01 to 2026-05-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)EVP, Chief R&D Officer62 legs · 9,607 sh · $558,6199

Form 4 filings — Friberg Gregory R

FiledFormIssuerReported transactionsSource
2026-05-114BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 3,281 @ $53.85EDGAR
2026-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 19,150 @ $0 · Tax withholding (F): 1,629 @ $56.05 · Grant/award (A): 45,600 (derivative) @ $0EDGAR
2026-02-264BIOMARIN PHARMACEUTICAL INC (BMRN)Sale (S): 6,326 @ $60.38EDGAR
2025-10-024BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 3,304 @ $54.16EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 17,750 @ $0 · Grant/award (A): 41,170 (derivative) @ $0EDGAR
2024-10-014BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 21,190 @ $0 · Grant/award (A): 7,870 @ $0 · Grant/award (A): 49,850 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2038768 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →